In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/happy-world-ip-day-from-ipkat.html The AmeriKat happily wonders at a leaf (and not her laptop) It is a sunny day in Central London. Looking outside at the blue skies, budding trees and residents walking their dogs you wouldn’t think it was a day unlike any other on the 26th of April. Until you... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/never-too-late-if-you-missed-ipkat-last_26.html Have you missed the IPKat’s latest posts? Then this recap is for you! Four’s a Crowd? Copyright The DSM Directive still dominates the IPKat pages [see earlier contributions here, here, here, here and here], and now in its transposition phase. Kat Friend Lisa Moser brought us the news about... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/fibrogen-v-akebia-arnold-lj-addresses.html Courts, lawyers and legal scholars in many places across the globe have adjusted to the new normal that COVID-19 has imposed. It’s far from ideal but with a range of special measures, from extended deadlines [here] to virtual hearings [here], we make do as well as we can. At... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/is-there-any-connection-between.html Discovery Limited, a holding company of Discovery Life Limited (Discovery Life) and Discovery Vitality (Pty) Limited (Discovery Vitality), is the proprietor of two trademarks, “Discovery” and “Vitality” – registered in relation to insurance services, among others. Discovery Life offers life insurance services while Discovery Vitality offers a vitality wellness... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/an-unimpressed-lj-floyd-strikes-out.html Regen versus Estar was one of the key decisions of the High Court last year (Regen Lab v Estar [2019] EWHC 63 (Pat), IPKat here). Regen’s EP(UK) patent for its lucrative platelet purification (PRP) technology was revoked for lacking novelty in view of prior use. The case was part of the international dispute... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/no-european-qualifying-examination-will.html In what now seems like a different era, the EPO announced that the 2020 EQE was to be postponed in view of the emerging COVID-19 crisis (IPKat here). At that time, the full scale of the health emergency had not yet become apparent. There was hope that the 2020... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/guest-post-insights-on-pharmaceuticals.html COVID-19 is the topic of the days (or of the months to be more accurate), and this Kat is more than happy to post the Guest post by IPKat friends Gian Paolo Di Santo, Avv. Gabriele Girardello, Avv. Greta Cucinella in the subject. Here is what Gian Paolo Gabriele... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/around-blogs_22.html This Kat is looking for a good anti-wrinkle cream Welcome to this week’s roundup of interesting stories from around the IP blogosphere. CopyrightIf you’ve been putting your socially-distanced time to good use (i.e. spending a lot of time on Netflix), you may have become a fan of a certain... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/in-memoriam-albert-uderzo-how-asterixs.html Albert Uderzo, born Alberto Aleandro Uderzo, passed away on 24 March 2020 at age 92. Uderzo’s name is best known to the world as the illustrator, and later (after the death of his co-author René Goscinny), scriptwriter of the Asterix comic books. The comic series, which recently turned 60,... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/04/superman-enjoys-high-degree-of.html In an interesting decision delivered earlier this month concerning an opposition filed by DC Comics, which owns the figurative mark “SUPERMAN” (pictured below), the EUIPO Opposition Division acknowledged that this mark enjoys a high degree of recognition and, as such, is eligible for protection under Article 8(5) EU Trade... Continue reading
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION